Keros Therapeutics
KROS
#7006
Rank
A$0.66 B
Marketcap
$16.32
Share price
-0.70%
Change (1 day)
-83.03%
Change (1 year)

EPS for Keros Therapeutics (KROS)

EPS in 2023 (TTM): -$6.81

According to Keros Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.48. In 2022 the company made an earnings per share (EPS) of -$6.83 a decrease over its 2021 EPS that were of -$4.15.

EPS history for Keros Therapeutics from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.81-0.38%
2022-$6.8364.68%
2021-$4.154.65%
2020-$3.9771.14%
2019-$2.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.59-51.98%๐Ÿ‡บ๐Ÿ‡ธ USA